SEC Form 4 · accession 0001144204-18-032121
Harvard Apparatus Regenerative Technology, Inc. · HRGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas McNaughton
Officer — Chief Financial Officer
Period of report
May 29, 2018
Accepted (ET)
May 31, 2018 · 8:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001563665
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.72 | May 29, 2018 | A | 104,643 | A | — | May 29, 2028 | Common Stock, par value $0.01 per share | 104,643 | 104,643 | D |
| Stock Option (right to buy)F2 | $2.72 | May 29, 2018 | A | 104,643 | A | — | May 29, 2028 | Common Stock, par value $0.01 per share | 104,643 | 104,643 | D |
Explanation of responses
- F1Incentive Stock Option shares that vest in four equal installments on December 31, 2018, 2019, 2020 and 2021.
- F2Non-Qualified Stock Option shares that vest based on certain performance milestones.
Remarks
This form has been signed under power of attorney.